Loading CNTX…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("CNTX","financials")Full statements spill as a table. For one cell: =jivedata("CNTX","Revenue") or =jivedata("CNTX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
CNTX • CIK 0001842952
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Research and Development Expense (Excluding Acquired in Process Cost) | $17,782.731 | $22,701.335 | $31,856.252 | $40,107.583 |
| General and Administrative Expense | $7,289.885 | $7,222.565 | $7,846.379 | $8,618.833 |
| Operating Income (Loss) | $-25,072.616 | $-29,923.9 | $-39,702.631 | $-48,726.416 |
| Investment Income, Interest | — | $3,200.224 | $3,378.545 | $2,455.058 |
| Other Nonoperating Income (Expense) | — | $-1.428 | $200.471 | $313.516 |
| Net Income (Loss) Attributable to Parent | $-23,964.211 | $-26,725.104 | $-36,123.615 | $-45,957.842 |
| Weighted Average Number of Shares Outstanding, Basic | 15,966,053 | 58,416,141 | 95,185,683 | 95,182,466 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 8,024,031 | 9,133,615 | 11,728,500 | 14,369,560 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $14,449.827 | $94,429.824 | $65,995.228 | $42,990.371 |
| Prepaid Expense and Other Assets, Current | $1,597.384 | $3,466.16 | $2,358.474 | $2,828.491 |
| Operating Lease, Right-of-Use Asset | $0 | $218.816 | $110.41 | $241.224 |
| Assets, Current | $16,047.211 | $97,895.984 | $68,353.702 | $45,818.862 |
| Property, Plant and Equipment, Net | $15.524 | $11.959 | $29.656 | $74.068 |
| Assets | $16,062.735 | $98,126.759 | $68,493.768 | $46,134.154 |
| Operating Lease, Liability, Noncurrent | — | $112.064 | $0 | $77.524 |
| Liabilities | $4,191.715 | $2,860.497 | $8,020.041 | $7,962.103 |
| Accounts Payable, Current | $2,383.016 | $1,452.188 | $2,532.887 | $3,288.209 |
| Accrued Liabilities, Current | $1,808.699 | $1,188.929 | $5,375.09 | $4,428.902 |
| Operating Lease, Liability, Current | $0 | $107.316 | $112.064 | $167.468 |
| Liabilities, Current | $4,191.715 | $2,748.433 | $8,020.041 | $7,884.579 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $15.966 | $89.704 | $91.879 | $91.879 |
| Additional Paid in Capital | $79,909.644 | $189,956.252 | $191,285.157 | $192,222.479 |
| Retained Earnings (Accumulated Deficit) | $-68,054.59 | $-94,779.694 | $-130,903.309 | $-154,142.307 |
| Stockholders' Equity Attributable to Parent | $11,871.02 | $95,266.262 | $60,473.727 | $38,172.051 |
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| Preferred Stock, Shares Outstanding | 0 | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 100,000,000 | 200,000,000 | 200,000,000 | 300,000,000 |
| Common Stock, Shares, Issued | 15,966,053 | 89,704,194 | 91,879,177 | 91,879,177 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $-23,964.211 | $-26,725.104 | $-36,123.615 | $-45,957.842 |
| Net Cash Provided by (Used in) Operating Activities | $-21,047.618 | $-14,556.434 | $-26,385.38 | $-33,970.93 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-21,047.618 | $79,979.997 | $-28,434.596 | $-40,526.676 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $14,449.827 | $94,429.824 | $65,995.228 | $31,171.597 |
| Payments to Acquire in Process Research and Development | $0 | $14,750 | $2,000 | $6,500 |
| Share-based Payment Arrangement, Noncash Expense | $1,076.865 | $841.867 | $1,331.08 | $1,585.571 |
| Payments to Acquire Property, Plant, and Equipment | $0 | $7.316 | $33.948 | $55.746 |
| Depreciation, Depletion and Amortization | $12.044 | $10.881 | $16.251 | $19.465 |
| Net Cash Provided by (Used in) Investing Activities | $0 | $-14,757.316 | $-2,033.948 | $-6,555.746 |
| Proceeds from Issuance of Private Placement | — | $94,758.747 | $0 | $0 |
| Payments of Stock Issuance Costs | $0 | — | $15.268 | $15.268 |
| Proceeds from Issuance of Common Stock | — | $14,535 | $0 | $0 |
| Net Cash Provided by (Used in) Financing Activities | $0 | $109,293.747 | $-15.268 | $0 |
| Issuance of Stock and Warrants for Services or Claims | $0 | $15.268 | $2.175 | $2.175 |
| Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | $0 | $260.638 | $0 | $201.058 |
| Increase (Decrease) in Prepaid Expense and Other Assets | $-758.829 | $1,868.776 | $-1,107.686 | $-602.697 |
| Increase (Decrease) in Accounts Payable | $1,446.686 | $-946.096 | $1,095.967 | $892.329 |
| Increase (Decrease) in Accrued Liabilities | $-407.47 | $-619.77 | $4,186.161 | $384.322 |
| IncreaseDecreaseInOperatingLeaseLiability | $-55.078 | $-41.258 | $-107.316 | $-123.385 |